RJA
RBOT

Raymond James & Associates’s Vicarious Surgical RBOT Stock Holding History

Raymond James & Associates’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,413
Closed -$1.08M – 4259
2021
Q3 		$1.08M Buy
+2,413
New +$764K ﹤0.01% 2530

Other funds holding RBOT

VS
VK Services Menlo Park, California $1.01M AUM 157.81% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $8.89B AUM 39.91% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $1.36B AUM 336.43% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $154M AUM 453.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James & Associates's RBOT Position: Q4 2021 in Review

Raymond James & Associates sold out of Vicarious Surgical (RBOT) in Q4 2021, closing a stake of 2,413 shares — an estimated $1.08M sold.

Raymond James & Associates first reported a position in RBOT in Q3 2021 and held it in 1 quarter. The position peaked at $1.08M in Q3 2021. 53 funds tracked by Wall St. Rank hold RBOT as of Q4 2021.

  • Raymond James & Associates reported no remaining Vicarious Surgical position as of Q4 2021 after selling out during the quarter.
  • Raymond James & Associates sold 2,413 Vicarious Surgical shares in Q4 2021, an estimated $1.08M.
  • Raymond James & Associates first reported a position in Vicarious Surgical in Q3 2021 and held it in 1 quarter.
  • Raymond James & Associates's Vicarious Surgical position peaked at $1.08M in Q3 2021.
  • 53 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2021.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.